Thompson Siegel & Walmsley LLC grew its stake in shares of MAXIMUS, Inc. (NYSE:MMS) by 54.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 979,701 shares of the health services provider’s stock after purchasing an additional 345,555 shares during the period. Thompson Siegel & Walmsley LLC owned approximately 1.50% of MAXIMUS worth $60,849,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Renaissance Technologies LLC bought a new position in MAXIMUS during the fourth quarter valued at $2,054,000. Millennium Management LLC bought a new position in MAXIMUS during the fourth quarter valued at $1,259,000. Wells Fargo & Company MN increased its position in MAXIMUS by 114.6% during the first quarter. Wells Fargo & Company MN now owns 230,006 shares of the health services provider’s stock valued at $15,349,000 after acquiring an additional 122,824 shares during the last quarter. Dupont Capital Management Corp increased its position in MAXIMUS by 277.9% during the first quarter. Dupont Capital Management Corp now owns 50,530 shares of the health services provider’s stock valued at $3,372,000 after acquiring an additional 37,160 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado increased its position in MAXIMUS by 2.4% during the first quarter. Public Employees Retirement Association of Colorado now owns 486,125 shares of the health services provider’s stock valued at $32,444,000 after acquiring an additional 11,264 shares during the last quarter. Hedge funds and other institutional investors own 93.44% of the company’s stock.

MMS stock traded up $0.60 during mid-day trading on Friday, reaching $66.24. 256,095 shares of the stock traded hands, compared to its average volume of 234,961. MAXIMUS, Inc. has a one year low of $60.27 and a one year high of $72.71. The stock has a market capitalization of $4.21 billion, a price-to-earnings ratio of 19.76, a price-to-earnings-growth ratio of 2.53 and a beta of 1.19.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 9th. The health services provider reported $0.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.82 by $0.09. The business had revenue of $597.90 million for the quarter, compared to analysts’ expectations of $591.91 million. MAXIMUS had a net margin of 9.28% and a return on equity of 21.51%. The business’s revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.86 earnings per share. equities research analysts forecast that MAXIMUS, Inc. will post 3.24 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, August 31st. Stockholders of record on Wednesday, August 15th were issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend was Tuesday, August 14th. MAXIMUS’s payout ratio is presently 5.94%.

MAXIMUS declared that its board has approved a share buyback program on Monday, June 25th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the health services provider to purchase up to 4.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Separately, Zacks Investment Research cut shares of MAXIMUS from a “hold” rating to a “sell” rating in a research report on Tuesday, May 22nd.

In other news, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $61.91, for a total value of $61,910.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Paul R. Lederer sold 7,500 shares of the company’s stock in a transaction dated Tuesday, August 14th. The stock was sold at an average price of $64.05, for a total transaction of $480,375.00. Following the completion of the transaction, the director now owns 62,535 shares in the company, valued at $4,005,366.75. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Featured Article: Technical Analysis

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.